Synthetic cathinone adulteration of illegal drugs - PubMed (original) (raw)

Review

Synthetic cathinone adulteration of illegal drugs

Chicora F Oliver et al. Psychopharmacology (Berl). 2019 Mar.

Abstract

Rationale: Current prevalence estimates of synthetic cathinone ("bath salt") use may be underestimates given that traditional metrics (e.g., surveys, urinalysis) often fail to capture the emergent issue of synthetic cathinone adulteration of more common illegal drugs, such as ecstasy (3,4-methylenedioxymethamphetamine).

Objectives: This review examines the evolution of synthetic cathinones and prevalence of use over the past decade in the United States. We also review methods of self-report and biological testing of these compounds as well as adverse outcomes associated with adulterated drug use.

Results: Synthetic cathinone use emerged in the United States by 2009 with use associated with tens of thousands of poisonings. Reported poisonings and self-reported use have substantially decreased over the past five years. However, our review suggests that current estimates of use are underestimates due to underreporting stemming primarily from unknown or unintentional use of adulterated formulations of relatively popular illegal drugs, such as ecstasy.

Conclusions: While intentional synthetic cathinone use has decreased in recent years, evidence suggests that prevalence of use is underestimated. Testing of drugs and/or biological specimens can improve the accuracy of synthetic cathinone use estimates. Furthermore, we advocate that researchers and clinicians should become better aware that exposure to these potent compounds (e.g., as adulterants) often occurs unknowingly or unintentionally. To improve our understanding of synthetic cathinone adulteration, research utilizing a combinatorial approach (survey and biological testing) will help more accurately estimate the prevalence and impact of this public health issue.

Keywords: Addiction; Adulteration; Ecstasy; Novel psychoactive substances; Synthetic cathinones.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: There are no conflicts of interest to report.

Similar articles

Cited by

References

    1. Alles GA, Fairchild MD, Jensen M (1961) Chemical pharmacology of Catha edulis. J Med Pharm Chem 3:323–52 - PubMed
    1. Anneken JH, Angoa-Pérez M, Kuhn DM (2015) 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem 133:211–222. doi: 10.1111/jnc.13048 - DOI - PMC - PubMed
    1. Alvarez J-C, Fabresse N, Larabi IA (2018) Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review. Curr Pharm Des 23:5487–5495. doi: 10.2174/1381612823666170704124156 - DOI - PubMed
    1. American Association of Poison Control Centers 2016. Bath salts data. https://aapcc.s3.amazonaws.com/files/library/Bath_Salts_Web_Data_through... Accessed on 30 November 2018
    1. Banks ML, Worst TJ, Rusyniak DE, Sprague JE (2014) Synthetic Cathinones (“Bath Salts”). J Emerg Med 46:632–642. doi: 10.1016/j.jemermed.2013.11.104 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources